Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan by K. Namikawa, S. Mori, Y. Kiniwa, T. Takenouchi, M. Nakamura, K. Oashi, S. Yoshikawa, Y. Muto, H. Uchi, K. Yoshino, T. Maekawa, S. Ohe, H. Uhara, Y. Ichigozaki, J. Asai, Y. Nakamura, S. Ishizuki, T. Matsuzawa, H. Kitagawa, M. Nomura, T. Funakoshi, S. Matsushita, T. Maeda, N. Hatta, K. Tsutsui, T. Nakagawa, T. Hoashi, H. Ishikawa, K. Nakama, T. Ito, T. Miyagawa, A. Nishizawa, T. Yanagi, Y. Kato, S. Fujiwara, Y. Yamamoto, H. Iwata, D. Ogata, Y. Fujisawa

Get full text